Definitive Contract HHSN268200900047C
Award Date 9/15/09
Potential Completion Date 3/20/20
Potential Value $18M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Birmingham, AL 35233, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for a biomedical clinical trial to study systolic blood pressure, awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to the University of Utah's Office of Sponsored Projects Division. The contract has a ceiling value of $24,519,297.30 and is a definitive contract with cost-no-fee pricing. The award is not set aside for any specific type of business. The University of Utah, a major...
- This is a federal contract award from the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Wake Forest University Health Sciences (WFUHS) to conduct the Systolic Blood Pressure Intervention Trial (SPRINT), a biomedical clinical trial studying systolic blood pressure. The contract is a definitive, firm-fixed-price contract with a ceiling value of $21,372,432.75 and a period of performance through March 20, 2020. WFUHS, a private...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study - Birmingham Field Center. The $7,699,918.00 cost-no-fee contract has a period of performance through June 30, 2034 and does not have a set-aside designation. UAB is a prominent public research university with extensive capabilities in biomedical research, clinical...
- This is a $1,050,298.53 federal contract award to the University of Alabama at Birmingham (UAB) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for Task Area B under the Coronary Artery Risk Development in Young Adults (CARDIA) program, with a period of performance from November 14, 2019, to October 31, 2021, and an ultimate completion date of January 31, 2023. UAB is the prime contractor for this cost-no-fee...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Case Western Reserve University (CWRU) for the Systolic Blood Pressure Intervention Trial (SPRINT) Clinical Coordinating Center (CCN). The contract, valued at $19,535,881.06, is a definitive, firm fixed-price contract with a period of performance ending on March 20, 2020. The contract does not have a set-aside designation. CWRU, a prominent private...
- This is a Cost No Fee definitive contract awarded to the University of Alabama at Birmingham (UAB) by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, for the Long Term Oxygen Treatment Trial. The contract has a ceiling value of $3,648,599.89 and a period of performance ending on March 31, 2016. The contract has no set-aside designation. As a leading research university, UAB has extensive experience conducting biomedical...
- This is a $43,426,290.11 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Wake Forest University Health Sciences to conduct a biomedical clinical trial studying systolic blood pressure. The contract, which has no set-aside designation, is a definitive contract with a cost-no-fee pricing type. The contract is part of the SPRINT major program and has a period of performance ending on March 21, 2019. Wake Forest University Health Sciences is a...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $72.0 million cost-no-fee definitive contract to the University of Alabama at Birmingham (UAB) on May 21, 2004, for operation of a field center supporting the Coronary Artery Risk Development in Young Adults (CARDIA) Study. This longitudinal epidemiological research initiative tracks cardiovascular risk factors and disease development in a cohort of young adults, with the Birmingham field center responsible for participant...
- The University of Alabama at Birmingham (UAB) was awarded a federal contract by the National Heart, Lung, and Blood Institute (NHLBI) for $7,967,653.41 to support the Coronary Artery Risk Development in Young Adults (CARDIA) study. The contract, which runs from July 2018 to June 2023, does not have a set-aside designation. As the prime contractor, UAB is responsible for various tasks including blood sample tracking and inventory, DNA extraction and distribution, data security, and freezer...
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham a delivery order valued at $771,759 to support the Coronary Artery Risk Development in Young Adults (CARDIA) Study Birmingham Field Center. This cost-no-fee delivery order, issued March 13, 2026, will operate through January 31, 2037, and is based at UAB's Birmingham, Alabama location. The contract carries no set-aside designation and reflects the institute's continued investment in the CARDIA Study,...